APA (7th ed.) Citation

Marzieh Zargaran, Fatemeh Soleymani, Saman Ahmad Nasrollahi, Meysam Seyedifar, & Mohammad Mehdi Ashrafian Rahaghi. (2021). Cost-utility and budget impact analysis of adding-on apremilast to biologic therapy in the treatment of moderate to severe plaque psoriasis, an Iranian payer perspective. Wolters Kluwer Medknow Publications.

Chicago Style (17th ed.) Citation

Marzieh Zargaran, Fatemeh Soleymani, Saman Ahmad Nasrollahi, Meysam Seyedifar, and Mohammad Mehdi Ashrafian Rahaghi. Cost-utility and Budget Impact Analysis of Adding-on Apremilast to Biologic Therapy in the Treatment of Moderate to Severe Plaque Psoriasis, an Iranian Payer Perspective. Wolters Kluwer Medknow Publications, 2021.

MLA (9th ed.) Citation

Marzieh Zargaran, et al. Cost-utility and Budget Impact Analysis of Adding-on Apremilast to Biologic Therapy in the Treatment of Moderate to Severe Plaque Psoriasis, an Iranian Payer Perspective. Wolters Kluwer Medknow Publications, 2021.